Gardner Lewis Asset Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Gardner Lewis Asset Management’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-320,000	Closed	-$6.38M	–	93
2022 Q3	$6.38M	Buy	+320,000	New	+$4.22M	1.41%	28

Gardner Lewis Asset Management's FMTX Position: Q4 2022 in Review

Gardner Lewis Asset Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 320,000 shares — an estimated $6.38M sold.

Gardner Lewis Asset Management first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $6.38M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Gardner Lewis Asset Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Gardner Lewis Asset Management sold 320,000 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $6.38M.
Gardner Lewis Asset Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
Gardner Lewis Asset Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $6.38M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Gardner Lewis Asset Management's 13F filing for Q4 2022, filed 10 Feb 2023.